| Safety and Efficacy of MBF-118 in Patients with Crohn Disease (NCT05940558) | Medibiofarma S.L. | 2023-04-12 |
| Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency (NCT05593588) | Avni Joshi | 2023-04-12 |
| A Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast Cancer (NCT06685796) | BeBetter Med Inc | 2023-04-12 |
| Trial of the Combined Use of Thiamine and Biotin in Patients With Huntington's Disease (NCT04478734) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2023-04-12 |
| SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty (NCT05752461) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2023-04-12 |
| A Study Evaluating Efficacy and Safety of Multiple Treatment Combinations in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (Morpheus-Head and Neck Cancer) (NCT05459129) | Hoffmann-La Roche | 2023-04-12 |
| Phase II Clinical Trial to Evaluate the Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Capsule and Chemotherapy in the Treatment of Immunoresistant Advanced Non-small Cell Lung Cancer (NCT06141226) | Tianjin Medical University Cancer Institute and Hospital | 2023-04-12 |
| Efficacy of Tranexamic Acid (TXA) in Humerus ORIF (NCT05802238) | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 2023-04-12 |
| A Study to Assess the Safety and Efficacy of Ruxolitinib Cream in Participants With Genital Vitiligo (NCT05750823) | Incyte Corporation | 2023-04-11 |
| An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque Psoriasis (NCT05858047) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2023-04-11 |
| Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients (NCT06009627) | Tianjin Medical University Cancer Institute and Hospital | 2023-04-11 |
| Study to Assess EXS21546 in Combination in Patients With Advanced Solid Tumours (NCT05920408) | Exscientia AI Limited | 2023-04-11 |
| Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis (NCT05590455) | ANRS, Emerging Infectious Diseases | 2023-04-11 |
| Fluorescence Imaging With Indocyanine Green(ICG) in Endoscopic Spinal Surgery (NCT05808140) | Zhongnan Hospital | 2023-04-11 |
| Inhaled Corticosteroids (ICS) on Pulmonary Endothelial Function in COPD (NCT05607719) | University of Miami | 2023-04-11 |
| Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial (NCT05632627) | University of Colorado, Denver | 2023-04-11 |
| Modified Huang-Lian-Jie-Du Decoction (MHLJDD) for Atopic Dermatitis in Children (NCT05613062) | Chinese University of Hong Kong | 2023-04-11 |
| ADJUnct Semaglutide Treatment in Type 1 Diabetes (NCT05537233) | Viral N. Shah | 2023-04-11 |
| Efficacy of QBKPN Site-Specific Immunomodulator in Improving Innate Immune Function & Reducing Respiratory Tract Infection in Older Adults (NCT05421325) | Qu Biologics Inc. | 2023-04-11 |
| Neoadjuvant Cadonilimab Plus Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cancer (NCT05792735) | Shenzhen People's Hospital | 2023-04-11 |
| Safety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM (NCT05749133) | XuYan | 2023-04-10 |
| Electroencephalogram (EEG) Enhanced Transcranial Magnetic Stimulation (eTMS) for Chronic Trauma and Stressor-Related Disorders (TSRD) (NCT05835414) | Marcia Bockbrader, MD PhD | 2023-04-10 |
| The Women TAF-FTC Benchmark Study (NCT05140954) | University of Washington | 2023-04-10 |
| Phase 2 Study of Neoadjuvant PEMbrolizumab Before Radical PROstatectomy in High-risk Prostate Cancer Patients (NCT04565496) | IRCCS San Raffaele | 2023-04-10 |
| Anlotinib Plus TQB2450 Combined With Nab-paclitaxel and Cisplatin as First-line Treatment for Advanced Biliary Tract Cancer (NCT05812430) | The First Affiliated Hospital of Zhengzhou University | 2023-04-10 |
| Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients (NCT05769582) | Memo Therapeutics AG | 2023-04-10 |
| Using rTMS to Explore Neural Mechanisms of Stress-Induced Opioid Use (NCT04181515) | Wayne State University | 2023-04-10 |
| Bumetanide in Patients With Alzheimer's Disease (NCT06052163) | Stanford University | 2023-04-10 |
| MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma (NCT05286788) | Nationwide Children's Hospital | 2023-04-10 |
| Regeneron AA Multicenter (Dupilumab) (NCT05551793) | Emma Guttman | 2023-04-10 |
| Repetitive Transcranial Magnetic Stimulation, a Form of Non-invasive Brain Stimulation, as a Possible Treatment for Post-stroke Fatigue. (NCT05584124) | VA Office of Research and Development | 2023-04-10 |
| Mupirocin 2% Ointment Vs Spray Antibiotics on Temporary Hemodialysis Catheter (NCT05874219) | Future University in Egypt | 2023-04-10 |
| Tocilizumab for Acute Chest Syndrome (NCT05640271) | University of Chicago | 2023-04-10 |
| rTMS of Limbic Circuitry in Stress Modulation in Healthy Volunteers (NCT04180969) | Wayne State University | 2023-04-10 |
| Study of OT202 in Treating Moderate to Severe Dry Eye (NCT06435182) | Ocumension Therapeutics (Shanghai) Co., Ltd | 2023-04-10 |
| Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients (NCT05825443) | Nanfang Hospital, Southern Medical University | 2023-04-10 |
| Neoadjuvant Fluzoparib in Germline BRCA-mutated Three-negative Breast Cancer Breast Cancer (NCT05834582) | The First Affiliated Hospital with Nanjing Medical University | 2023-04-08 |
| Pyrotinib in Women With High-risk in Early Stage Breast Cancer (NCT05834764) | The First Affiliated Hospital with Nanjing Medical University | 2023-04-08 |
| Lazertinib+Pemetrexed/Carboplatin in Patients With EGFR Sensitizing Mutation Positive Recurrent or Metastatic Non-Small Cell Lung Cancer Failed to Prior Lazertinib (NCT05786430) | Yonsei University | 2023-04-07 |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial (NCT05564377) | National Cancer Institute (NCI) | 2023-04-07 |
| Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes (NCT05626712) | Creative Medical Technology Holdings Inc | 2023-04-07 |
| A Clinical Study Evaluating the Safety, Tolerability, and Efficacy of MT1013 in Hemodialysis Subjects With Secondary Hyperparathyroidism (NCT06747247) | Shaanxi Micot Pharmaceutical Technology Co., Ltd. | 2023-04-07 |
| A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic Characteristics, and Immunogenicity of Plonmarlimab in Subjects With Rheumatic and Immunological Disease-associated Haemophagocytic Lymphohistiocytosis (HLH) (Also Known as Macrophage Activation Syndrome (MAS)) (NCT07034209) | TJ Biopharma Co., Ltd. | 2023-04-07 |
| A Trial of HRS8179 on Brain Swelling After Large Hemispheric Infarction (NCT05690711) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2023-04-07 |
| A Study of XmAb23104 in People With Sarcoma (NCT05879185) | Memorial Sloan Kettering Cancer Center | 2023-04-06 |
| Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of Investigational Lubricating Eye Drops (NCT05814367) | Johnson & Johnson Vision Care, Inc. | 2023-04-06 |
| SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung Cancer (NCT05570825) | University of Washington | 2023-04-06 |
| Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients (NCT05844046) | Enrico De Toni | 2023-04-06 |
| Phase 2 Clinical Trial of GH001 in Bipolar II Disorder (NCT05839509) | GH Research Ireland Limited | 2023-04-06 |
| Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke (NCT05686642) | Shanghai Pharmaceuticals Holding Co., Ltd | 2023-04-06 |
| Palbociclib Combined With Afatinib for Advanced Squamous Carcinoma of Esophagus or Gastroesophageal Junction (NCT05865132) | AIPING ZHOU | 2023-04-06 |
| A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma (NCT05800366) | Jennifer Crombie, MD | 2023-04-06 |
| A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma (NCT05126719) | Shanghai Miracogen Inc. | 2023-04-06 |
| Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-ALL or T-LBL (NCT05464836) | M.D. Anderson Cancer Center | 2023-04-06 |
| Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia (NCT05643196) | NYU Langone Health | 2023-04-06 |
| ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers (NCT05616624) | Washington University School of Medicine | 2023-04-05 |
| A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions (NCT05816382) | Takeda | 2023-04-05 |
| Peripheral Oxytocin and Touch (NCT05326776) | University of California, San Diego | 2023-04-05 |
| Efficacy and Safety of SBRT Followed by Tislelizumab Plus Cetuximab and Irinotecan in Patients With Previously Treated RAS Wild-type Advanced Refractory Colorectal Cancer (NCT05799443) | Fujian Cancer Hospital | 2023-04-05 |
| Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies (NCT05371054) | National Cancer Institute (NCI) | 2023-04-05 |
| A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants. (NCT05683457) | ModernaTX, Inc. | 2023-04-05 |
| A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma (NCT05704049) | Sanofi | 2023-04-05 |
| International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab (NCT05669989) | Sanofi | 2023-04-05 |
| A Study to Evaluate the Efficacy and Safety of AD-209 (NCT05631990) | Addpharma Inc. | 2023-04-05 |
| Trivalent Salmonella Conjugate Vaccine (TSCV) (NCT05784701) | University of Maryland, Baltimore | 2023-04-05 |
| A First-in-human Study of IBI354 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors (NCT05636215) | Innovent Biologics (Suzhou) Co. Ltd. | 2023-04-04 |
| A Phase 2 Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects With Mac-off Retinal Detachment (NCT05730218) | ONL Therapeutics | 2023-04-04 |
| A Study of VRd-based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With New-diagnosed Multiple Myeloma (NCT05860036) | Institute of Hematology & Blood Diseases Hospital, China | 2023-04-04 |
| Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors (NCT05731947) | Syndax Pharmaceuticals | 2023-04-04 |
| Metformin and Nightly Fasting in Women With Early Breast Cancer (NCT05023967) | M.D. Anderson Cancer Center | 2023-04-04 |
| Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC (NCT05800340) | Guangdong Provincial People's Hospital | 2023-04-04 |
| Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant (NCT05579639) | Children's Hospital Medical Center, Cincinnati | 2023-04-04 |
| A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS) (NCT05795465) | GEn1E Lifesciences | 2023-04-04 |
| A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients (NCT06092606) | Monyan Pharmaceutical (Shanghai) Co., Ltd. | 2023-04-04 |
| Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (NCT05747924) | Avidity Biosciences, Inc. | 2023-04-04 |
| Effects of the Adjunctive Use of Hyaluronic Acid-based Gel in the Surgical Periodontal Treatment of Periodontitis (NCT06842511) | Ordu University | 2023-04-04 |
| MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI (NCT05730816) | Brigham and Women's Hospital | 2023-04-04 |
| The Safety and Efficacy of AlphaWave® L-Theanine on Adults Who Experience Moderate Stress on a Regular Basis (NCT05808595) | Ethical Naturals, Inc. | 2023-04-04 |
| 4 Courses vs 2 Courses of Pembrolizumab Combined With Carboplatin and Albumin-binding Paclitaxel of Neoadjuvant Therapy in HNSCC (NCT05980702) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-04-04 |
| A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS) (NCT05817669) | argenx | 2023-04-04 |
| Baricitinib for Refractory Takayasu Arteritis (NCT06662721) | Liu Tian | 2023-04-03 |
| Feasibility Study of A VoRo UrologIc ScaffolD (ARID) (NCT06275945) | Levee Medical, Inc. | 2023-04-03 |
| Phase II Clinical Study on the Efficacy and Safety of Naltrexone Implant in Patients With Alcohol Use Disorder (NCT07333638) | Shenzhen Sciencare Medical Industries Co., Ltd. | 2023-04-03 |
| The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects (NCT05786066) | Yale University | 2023-04-03 |
| Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis (NCT05769777) | Sanofi | 2023-04-03 |
| A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer (NCT05723562) | GlaxoSmithKline | 2023-04-03 |
| Efficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapy (NCT06586242) | Xijing Hospital | 2023-04-03 |
| Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer (NCT05838729) | Coordination Pharmaceuticals, Inc. | 2023-04-03 |
| A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso. (NCT05790889) | University of Oxford | 2023-04-03 |
| A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis (NCT05730725) | Bristol-Myers Squibb | 2023-04-03 |
| Treatment of Ectopic Calcification in Fahr's Disease or Syndrome (NCT05662111) | UMC Utrecht | 2023-04-03 |
| Eyelid Androgen Treatment in Dry Eye (NCT06154200) | Southern California College of Optometry at Marshall B. Ketchum University | 2023-04-02 |
| Caudal Block With Bupivacaine and Dexmedetomidine Versus TAP Block With Bupivacaine Alone for Postoperative Analgesia in Pediatric Undergoing Infraumbical Surgeries (NCT06183073) | Sohag University | 2023-04-02 |
| Research of SORD-CMT Natural History and Epalrestat Treatment (NCT05777226) | The Third Xiangya Hospital of Central South University | 2023-04-01 |
| NanO2 for Large Vessel Occlusion Stroke (NCT05389748) | NuvOx LLC | 2023-04-01 |
| A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD (NCT05686044) | Annovis Bio Inc. | 2023-04-01 |
| Immunological Basis for Benralizumab Activity in Chronic Obstructive Pulmonary Disease (COPD) (NCT05273359) | Temple University | 2023-04-01 |
| Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans (NCT05526144) | VA Office of Research and Development | 2023-04-01 |
| A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL (NCT05885386) | Peking Union Medical College Hospital | 2023-04-01 |
| Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors (NCT05790447) | Second Affiliated Hospital of Soochow University | 2023-04-01 |